Analysts Set Centene Co. (NYSE:CNC) PT at $85.15

Shares of Centene Co. (NYSE:CNCGet Free Report) have been given an average recommendation of “Moderate Buy” by the ten research firms that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $85.15.

Several analysts have issued reports on the company. UBS Group upped their target price on Centene from $72.00 to $79.00 and gave the company a “neutral” rating in a report on Thursday, December 21st. Cantor Fitzgerald increased their price target on Centene from $82.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, December 15th. Truist Financial raised their target price on Centene from $83.00 to $86.00 and gave the stock a “buy” rating in a research report on Thursday, December 21st. Wells Fargo & Company upgraded Centene from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $82.00 to $90.00 in a research note on Tuesday, January 2nd. Finally, Barclays assumed coverage on Centene in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $101.00 target price on the stock.

View Our Latest Stock Analysis on Centene

Insider Buying and Selling at Centene

In other Centene news, Director Lori Jean Robinson sold 10,000 shares of the stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now owns 11,455 shares of the company’s stock, valued at approximately $886,731.55. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, Director Lori Jean Robinson sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total value of $774,100.00. Following the sale, the director now owns 11,455 shares of the company’s stock, valued at approximately $886,731.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Kenneth J. Fasola sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $75.07, for a total value of $900,840.00. Following the completion of the sale, the president now directly owns 235,365 shares in the company, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Hedge Funds Weigh In On Centene

A number of hedge funds have recently modified their holdings of CNC. Operose Advisors LLC acquired a new stake in Centene during the third quarter valued at $25,000. Turtle Creek Wealth Advisors LLC acquired a new position in Centene during the 4th quarter worth $25,000. Coppell Advisory Solutions Corp. bought a new stake in shares of Centene during the 4th quarter valued at $25,000. ST Germain D J Co. Inc. bought a new stake in shares of Centene during the 2nd quarter valued at $26,000. Finally, OFI Invest Asset Management bought a new stake in shares of Centene during the 3rd quarter valued at $26,000. 90.92% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Down 0.8 %

Shares of NYSE:CNC opened at $75.47 on Thursday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $40.37 billion, a PE ratio of 15.37, a PEG ratio of 0.95 and a beta of 0.38. The business has a 50 day moving average of $77.20 and a two-hundred day moving average of $73.19. Centene has a 12-month low of $60.83 and a 12-month high of $81.42.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Centene had a return on equity of 14.26% and a net margin of 1.75%. The firm had revenue of $39.46 billion during the quarter, compared to the consensus estimate of $36.16 billion. During the same period in the prior year, the company earned $0.86 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. As a group, analysts forecast that Centene will post 6.75 EPS for the current year.

Centene Company Profile

(Get Free Report

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Analyst Recommendations for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.